Journal profile · Biochemistry & Molecular Biology
Critical Reviews in Biochemistry and Molecular Biology
ISSN 1040-9238 · eISSN 1549-7798 · Informa Healthcare · UNITED STATES · Bimonthly · Founded 1989
Critical Reviews in Biochemistry and Molecular Biology: CAS Zone 2 · Biology (2025 upgraded edition); impact factor 8.77; hybrid open access; median 91 days to acceptance (26 articles, last 24 months); community-reported acceptance: moderate; 13 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Critical Reviews in Biochemistry and Molecular Biology is published by Informa Healthcare and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are RNA and protein synthesis mechanisms, DNA Repair Mechanisms and RNA modifications and cancer, together about 25.3% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Aims and scopeJournal metrics Editorial board As the discipline of biochemistry and molecular biology have greatly advanced in the last quarter century, significant contributions have been made towards the advancement of general medicine, genetics, immunology, developmental biology, and biophysics. Investigators in a wide range of disciplines increasingly require an appreciation of the significance of current biochemical and molecular biology advances while, members of the biochemical and molecular biology community itself seek concise information on advances in areas remote from their own specialties. Critical Reviews in Biochemistry and Molecular Biology believes that well-written review articles prove an effective device for the integration and meaningful comprehension of vast, often contradictory, literature. Review articles also provide an opportunity for creative scholarship by synthesizing known facts, fruitful hypotheses, and new concepts. Accordingly, Critical Reviews in Biochemistry and Molecular Biology publishes high-quality reviews that organize, evaluate, and present the current status of high-impact, current issues in the area of biochemistry and molecular biology. Topics are selected on the advice of an advisory board of outstanding scientists, who also suggest authors of special competence. The topics chosen are sufficiently broad to interest a wide audience of readers yet focused enough to be within the competence of a single author or group of authors. Authors are chosen based on their activity in the field and their proven ability to produce a well-written publication. Invited authors are encouraged not only to review a field but to put forward their own unique perspective.Most articles published in the journal are invited. Unsolicited articles are occasionally considered if space is available. Prospective authors should provide a pdf file of the article and a cover letter through the submission system for editorial assessment. Articles are considered and advanced to peer review only if they cover topics of broad interest, are focused on mechanisms, systems, or novel methods related to Biochemistry and Molecular Biology, and are addressed by authors who have made substantial published contributions to the literature being reviewed. Read full aims and scope
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology10.2%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology8.6%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.6%
- Bacterial Genetics and BiotechnologyBiochemistry, Genetics and Molecular Biology6.1%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology5.5%
- DNA and Nucleic Acid ChemistryBiochemistry, Genetics and Molecular Biology5.2%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology5%
- Enzyme Structure and FunctionMaterials Science4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.77LetPub ·
- CiteScore 2026-06
- 13.7LetPub ·
- SJR 2026-06
- 2.55LetPub ·
- SNIP 2026-06
- 1.7LetPub ·
- h-index
- 97LetPub ·
- h-index
- 191OpenAlex ·
- i10-index
- 910OpenAlex ·
- 2-year mean citedness
- 9.21OpenAlex ·
- Self-citation rate
- 1.1%LetPub ·
- Share of gold OA articles
- 13.95%LetPub ·
Volume
- Articles per year
- 17LetPub ·
Articles by year OpenAlex count · 998 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 8 | 3 | 5 |
| 2025 | 13 | 8 | 90 |
| 2024 | 18 | 12 | 264 |
| 2023 | 8 | 4 | 295 |
| 2022 | 11 | 8 | 307 |
| 2021 | 41 | 26 | 1,765 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 75 days – 130 days
- Acceptance to online
- median 14 days (26 articles)
- Submission to online
- median 106 days
- Sample
- 26 articles with submission and acceptance dates (26 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Overview Open journals Open Select Dove Medical Press F1000Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1989
- ISSN
- 1040-9238
- Electronic ISSN
- 1549-7798
- Latest issue on the website
- Volume 61, Issue 1-3 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Critical Reviews in Biochemistry and Molecular Biology
What CAS zone is Critical Reviews in Biochemistry and Molecular Biology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Critical Reviews in Biochemistry and Molecular Biology is in Zone 2 of Biology, and in Zone 2 of the minor category Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Critical Reviews in Biochemistry and Molecular Biology?
The latest impact factor listed by LetPub is 8.77; CiteScore 13.7, h-index 191.
How long does peer review take at Critical Reviews in Biochemistry and Molecular Biology?
Based on the dates recorded on 26 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 75–130 days); the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Critical Reviews in Biochemistry and Molecular Biology?
According to LetPub and DOAJ records, Critical Reviews in Biochemistry and Molecular Biology is indexed in SCIE and Scopus.
Is Critical Reviews in Biochemistry and Molecular Biology open access, and what is the APC?
Critical Reviews in Biochemistry and Molecular Biology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .